Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director

MEDIZONE INTERNATIONAL INC (MZEI) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/19/2020 15-15D Form 15-15D - Suspension of duty to report [Section 13 and 15(d)]:
05/11/2018 8-K Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits
Docs: "Medizone International Announces Filing of Voluntary Chapter 7 Bankruptcy Proceeding Kalamazoo, Michigan, May 8, 2018. Medizone International, Inc."
04/25/2018 RW Form RW - Registration Withdrawal Request:
04/24/2018 8-K Termination of a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation o...
Docs: "In re: Medizone International, Inc. (Case 18-50412), Involuntary Bankruptcy Petition in the United States Bankruptcy Court for the District of Nevada",
"Kalamazoo, Michigan, April 20, 2018. Medizone International, Inc."
04/17/2018 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/13/2018 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/06/2018 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/03/2018 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
03/27/2018 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Shareholder Update"
03/22/2018 RW Form RW - Registration Withdrawal Request:
03/20/2018 10-K Annual Report for the period ended December 31, 2017
02/12/2018 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
02/05/2018 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended ; B. Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement a 8% convertible note of the Company, in the form attached hereto as Exhibit A , in the aggregate principal amount of US$152,500.00 issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, the “Note”), convertible into shares of common stock, $0.001 par value per share, of the Company , upon the terms...",
"Securities Purchase Agreement, by and between the Company and SBI Investments LLC, 2014-1",
"Convertible Promissory Note, made by the Company in favor of L2 Capital, LLC",
"Convertible Promissory Note, made by the Company in favor of SBI Investments LLC, 2014-1",
"Common Stock Purchase Warrant, by and between the Company and L2 Capital LLC",
"Common Stock Purchase Warrant, by and between the Company and SBI Investments LLC, 2014-1",
"Equity Purchase Agreement, by and between the Company and the Investors",
"Registration Rights Agreement, by and between the Company and the Investors",
"Trading Agreement, by and between L2 Capital LLC and SBI Investments LLC, 2014-1",
"Medizone Announces Completion of Financing Kalamazoo, Michigan, January 31, 2018. Medizone International, Inc."
02/01/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement between Medizone International, Inc. and Jude P. Dinges",
"Addendum to Employment Agreement between Medizone International and Jude P. Dinges",
"Medizone International Appoints Jude Dinges to Executive Team Kalamazoo, Michigan, January 30, 2018. Medizone International, Inc."
12/05/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Shareholder Update"
11/08/2017 10-Q Quarterly Report for the period ended September 30, 2017
11/03/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement between Medizone International, Inc. and Philip A. Theodore",
"Addendum to Employment Agreement between Medizone International and Philip A. Theodore",
"Addendum to Employment Agreement between Medizone International and Stephanie L. Sorensen",
"Medizone International Appoints Philip Theodore to Executive Team",
"Medizone International concludes exclusive Product Supply and License Agreement with Innovasource",
"AsepticSure â , the only disinfection system in the world that routinely achieves a minimum microbial kill of at least a thousand times greater than conventional cleaning methods,"
10/16/2017 8-K Quarterly results
09/19/2017 8-K Quarterly results
08/28/2017 8-K Quarterly results
08/24/2017 8-K Quarterly results
08/08/2017 10-Q Quarterly Report for the period ended June 30, 2017
06/22/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Medizone International Registered to Exhibit AsepticSure at the Military Health System’s Vendor Day",
"AsepticSure® Receives Full Approval of International Electrical Safety Standards AsepticSure approval of international safety standards clears path for global commercialization",
"Effective June 21, 2017, Daniel D. Hoyt",
"Investor Update (June 21, 2017)"
06/08/2017 8-K Form 8-K - Current report
05/31/2017 8-K Form 8-K - Current report
05/23/2017 8-K Form 8-K - Current report
05/12/2017 10-Q Quarterly Report for the period ended March 31, 2017
04/25/2017 8-K Form 8-K - Current report
04/07/2017 8-K Form 8-K - Current report
04/06/2017 8-K Form 8-K - Current report
03/22/2017 10-K Annual Report for the period ended December 31, 2016
03/03/2017 8-K Form 8-K - Current report
03/01/2017 8-K Form 8-K - Current report
02/28/2017 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy